With the introduction of the new highly effective antiviral therapies, there has been a dramatic increase in the use of the hepatitis C virus(HCV)-positive livers in HCV-positive recipients. In the majority of studies...With the introduction of the new highly effective antiviral therapies, there has been a dramatic increase in the use of the hepatitis C virus(HCV)-positive livers in HCV-positive recipients. In the majority of studies, HCV positivity was defined as a donor testing HCV Ab positive. In 2015, all Organ Procurement Organizations were mandated to perform and report HCV Nucleic Acid Amplification Testing(NAT) results on all deceased and living donors. Studies are not yet available on how organs are being utilized based on NAT status and whether NAT status affects recipient outcomes. Further studies are needed to maximize the use of these organs.展开更多
At the National S&T Conference held on 9 January, 2006 in Beijing, CAS received 43 prizes from China's 2005 S&T awards in the capacity of the lead research institution (or principal researcher). Among the ...At the National S&T Conference held on 9 January, 2006 in Beijing, CAS received 43 prizes from China's 2005 S&T awards in the capacity of the lead research institution (or principal researcher). Among the prize-winning projects, 17 were honored with the second prizes of the National Award for Natural Sciences, eight with the second prizes of the National Award for Invention, and 18 with the second prizes from the National Award for S&T Progress. A total of 314 projects received the 2005 national S&T awards nationwide. Of them, 38 were second-place winners from the National Award for Natural Sciences (first-place winners were vacant); 40 won the National Award for Invention (one first-place winner) and 236 won the National Award for S&T Progress (18 first-place winners). In addition, five foreign scientists received National Award for S&T Cooperation. The following is a brief account of some of the CAS projects.展开更多
文摘With the introduction of the new highly effective antiviral therapies, there has been a dramatic increase in the use of the hepatitis C virus(HCV)-positive livers in HCV-positive recipients. In the majority of studies, HCV positivity was defined as a donor testing HCV Ab positive. In 2015, all Organ Procurement Organizations were mandated to perform and report HCV Nucleic Acid Amplification Testing(NAT) results on all deceased and living donors. Studies are not yet available on how organs are being utilized based on NAT status and whether NAT status affects recipient outcomes. Further studies are needed to maximize the use of these organs.
文摘At the National S&T Conference held on 9 January, 2006 in Beijing, CAS received 43 prizes from China's 2005 S&T awards in the capacity of the lead research institution (or principal researcher). Among the prize-winning projects, 17 were honored with the second prizes of the National Award for Natural Sciences, eight with the second prizes of the National Award for Invention, and 18 with the second prizes from the National Award for S&T Progress. A total of 314 projects received the 2005 national S&T awards nationwide. Of them, 38 were second-place winners from the National Award for Natural Sciences (first-place winners were vacant); 40 won the National Award for Invention (one first-place winner) and 236 won the National Award for S&T Progress (18 first-place winners). In addition, five foreign scientists received National Award for S&T Cooperation. The following is a brief account of some of the CAS projects.
